Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/10/mosaic-rallies-as-dividend-usda-fertilizer-push-support-mos-outlook.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

Mosaic Rallies As Dividend, USDA Fertilizer Push Support MOS Outlook

TIM BOHEN•UPDATED OCT. 23, 2026, 4:18 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Mosaic Company (The) stocks have been trading up by 3.3 percent amid bullish sentiment on rising global fertilizer demand.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading MOS

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

  • Barclays lowered its price target on Mosaic to $22 from $26, even as the broader analyst community maintains an overweight rating and a higher mean price target of about $26.
  • Mizuho cut its price target on Mosaic to $22 from $25, while the consensus still rates the stock overweight with a mean target around $25.99.
  • The company is maintaining its quarterly dividend at $0.22 per share, payable 2026/12/18 to shareholders of record on 2026/12/04.
  • Executive Vice President – Operations Karen Swager will retire in 2027, with Senior Vice President and Chief Administrative Officer Walt Precourt assuming the EVP – Operations role on 2026/12/01.
  • USDA announced $1.34B in fertilizer investments that may indirectly affect Mosaic by expanding domestic fertilizer supply and infrastructure over time.

Candlestick Chart

Weekly Update Oct 19 – Oct 23, 2026: On Friday, October 23, 2026 Mosaic Company (The) stock [NYSE: MOS] is trending up by 3.3%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Materials industry expert:

Analyst sentiment – neutral

Mosaic’s current fundamentals reflect late-cycle fertilizer weakness and mediocre execution. Revenue of ~$12.1B is shrinking (three‑year CAGR -10%), with gross margin only 11% and LTM net margin negative despite a superficially strong 12% pre‑tax margin in better quarters. ROE and ROIC have flipped negative LTM, and Q2 showed a $266M loss with operating income below zero. Balance sheet is acceptable (D/E 0.54, interest cover 6.3), and equity trades at ~0.5x book with a covered 5% dividend but pressured free cash flow.

Technically, MOS is in a clear downtrend, trading sub‑$18 and making lower highs on the weekly tape (17.92 → 17.89 → 17.67 → 17.25 → 17.60). Intraday 5‑minute action shows weak bounces being sold, with heavier volume on down candles near 17.70–17.80 and thin bids below 17.40, confirming supply dominance. The key actionable level is resistance at $18.00: below this, rallies should be sold; only a weekly close above $18.00 would justify short‑term longs.

More Breaking News

Near‑term catalysts are modest. USDA’s fertilizer‑capacity push expands supply and ultimately pressures pricing across the sector, limiting upside for Mosaic versus diversified materials benchmarks. Management transition in operations appears orderly but does not change the investment case. Street targets have compressed to ~$22–26 yet still imply upside from current levels, supported by a maintained $0.22 quarterly dividend. Base case: range‑bound to mildly negative, with resistance at $18.00–18.50 and strong support near $16.00. Risk‑reward is Neutral at current prices.

Quick Financial Overview

The Mosaic Company (The) sits in a tricky fundamental spot that matters for short-term traders. Revenue over the last year is about $12.05B, but three‑year revenue growth is negative, down roughly 10%. Margins are thin: gross margin runs near 11%, and recent profit margin is slightly negative, helped by special charges and weaker pricing. That backdrop helps explain why Barclays and Mizuho both cut their MOS price targets to $22, even while the average target still hovers near $26 with an overweight stance.

On the balance sheet, Mosaic Company (The) carries moderate leverage. Total debt to equity is about 0.54, with interest coverage around 6.3 times, so the company can service its debt but does not have huge balance‑sheet flexibility. A current ratio of 1.3 shows a reasonable, not abundant, liquidity buffer. Valuation looks compressed, with price to sales near 0.49 and price to book near 0.52, which often attracts value‑oriented capital but does not guarantee a short‑term bounce.

Cash flow is where pressure shows. Latest quarterly free cash flow is roughly -$152.9M, hit by heavy capital spending and a working‑capital drag, even as management keeps paying a $0.22 quarterly dividend and a roughly 5% yield. For traders, that mix—negative free cash flow but ongoing payouts—can support the stock near key levels until the market loses confidence. Upcoming Q3 2026 earnings, already scheduled, are the next real test of whether MOS can turn operating cash flow and margins higher.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders